文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Promoting the term MAFLD: China in action.

作者信息

Zhang Xin-Lei, Fan Jian-Gao, Wei Lai, Shi Jun-Ping, Zheng Ming-Hua

机构信息

MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.

Center for Fatty Liver, Department of Gastroenterology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory Lab of Pediatric Gastroenterology and Nutrition, Shanghai, China.

出版信息

Lancet Gastroenterol Hepatol. 2022 Jul;7(7):598. doi: 10.1016/S2468-1253(22)00127-3.

DOI:10.1016/S2468-1253(22)00127-3
PMID:35709820
Abstract
摘要

相似文献

[1]
Promoting the term MAFLD: China in action.

Lancet Gastroenterol Hepatol. 2022-7

[2]
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.

BMC Gastroenterol. 2021-5-10

[3]
Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.

J Gastroenterol Hepatol. 2021-6

[4]
An Observational and Cross-Sectional Study of the Prevalence of Breast Lesions and Metabolic Dysfunction-Associated Fatty Liver Disease and their Relationship in China.

J Gastrointestin Liver Dis. 2022-3-19

[5]
Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.

Int J Environ Res Public Health. 2020-3-11

[6]
Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center.

J Diabetes Res. 2022

[7]
Moderation effect of economic status in the association between early life famine exposure and MAFLD in adulthood.

Liver Int. 2022-2

[8]
Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study.

BMJ Open. 2021-10-28

[9]
Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study.

Hepatobiliary Pancreat Dis Int. 2022-4

[10]
Relationship between the Metabolic Associated Fatty Liver Disease and Endometrial Thickness in Postmenopausal Women: A Cross-sectional Study in China.

Int J Med Sci. 2021

引用本文的文献

[1]
Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study.

Front Endocrinol (Lausanne). 2024

[2]
Association Between Nonalcoholic Fatty Liver Disease and the Risk of Cardiovascular Disease in the Middle-Age and Elderly Population of Northern China: A Cross-Sectional Study.

Diabetes Metab Syndr Obes. 2024-8-21

[3]
Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship.

Cureus. 2024-7-3

[4]
Activation of hepatic adenosine A1 receptor ameliorates MASH via inhibiting SREBPs maturation.

Cell Rep Med. 2024-3-19

[5]
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.

Hepatobiliary Surg Nutr. 2023-6-1

[6]
An international multidisciplinary consensus statement on MAFLD and the risk of CVD.

Hepatol Int. 2023-8

[7]
Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings.

J Cardiovasc Dev Dis. 2023-4-18

[8]
Vitamin C and vitamin D alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism the gut-liver axis.

Front Pharmacol. 2023-4-5

[9]
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention.

Cardiovasc Diabetol. 2022-12-3

[10]
Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide.

Med Sci Monit. 2022-8-15

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索